Crinetics Pharmaceuticals
CRNX
CRNX
246 hedge funds and large institutions have $5.1B invested in Crinetics Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 111 increasing their positions, 67 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
5% more funds holding
Funds holding: 234 → 246 (+12)
1.89% more ownership
Funds ownership: 105.6% → 107.49% (+1.9%)
Holders
246
Holding in Top 10
14
Calls
$1.7M
Puts
$654K
Top Buyers
| 1 | +$229M | |
| 2 | +$149M | |
| 3 | +$143M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$127M |
| 5 |
BlackRock
New York
|
+$49.4M |
Top Sellers
| 1 | -$31M | |
| 2 | -$27.6M | |
| 3 | -$20M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$10.5M |
| 5 |
DFO
Duquesne Family Office
New York
|
-$9.53M |